Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
AddBIO was founded in 2008 and has developed a solution to solve the real problem in the implant industry-weak bone. By coating any implant on the market with a bioactive nanolayer with a bone –strengthening drug, we know that millions of patients will experience better results and faster recovery.
Arthur D. Little is one of the wolrd's premier management consulting firms with offices in more than 30 countries. To the Healthcare and Life Science industry, we provide management consulting services in; strategy development and implementation, transformation change management, innovation management, performance improvement, opportunity assessment
The Swedish biopharmaceutical company BioArctic was founded by Prof. Lars Lannfelt and Dr. Pär Gellerfors, to explore important discoveries made by Prof. Lannfelt. These breakthrough discoveries, which have been internationally highly recognized, clarify the central role of protein misfolding in the neurodegenerative disease process in the human brain.
BioInvent is a research-based pharmaceutical company focused on discovery and development of innovative antibody-based drugs against cancer. BioInvent also develops antibody-based drugs in collaboration with partners who finance the development of new drugs and provide BioInvent with the right to milestone payments and royalties on sales.
BioThema is entirely focused on analytical applications of the firefly luciferase reaction. This reaction can be used for assays of number of cells, cell proliferation and cytotoxicity, all enzymes and metabolites participating in ATP forming or degrading reactions, reporter gene assays, immunoassays, rapid cell counting and hygiene control.
Biotec Pharmacon develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The company is spearheading research on products that may prevent or treat diseases caused by failure, imbalance and over-reaction of the immune system.
Birka BioStorage is the main secure and safe storage facility for valuable samples in Scandinavia. With a strong feeling of responsibility, and a relation of trust to our global Clients, we provide a wide range cGMP controlled storage and 24/7 sample logistic services, during the drug developement process.
CiToxLAB, our newly established group, created through the merger of CiT and LAB Research, provides a comprehensive range of preclinical and specialty services from our facilities in France, Canada, Denmark and Hungary. With a combined capacity in excess of 800 employees, 27 000 rodents, 5 000 non-rodents, including 1 200 non-human primates on-site, and purpose built facilities of 60 000 m2 (645, 000 ft2), the new group is a major global player in the preclinical outsourcing arena.
Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. Cobra has three GMP approved facilities in Sweden and the UK, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.
InDex Pharmaceuticals lead drug candidate is cobitolimod – a new type of drug that can help patients back to a normal life. InDex has also developed a platform of patent protected substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in treatment of various immunological diseases. The company is based at the Karolinska Institutet Science Park in Stockholm. Among the main shareholders are SEB Venture Capital, Industrifonden and NeoMed Management.
MYoroface is the company that has researched, developed, produced, patented and registered IQoro. IQoro is a new and unique neuromuscular treatment method that requires just 30 seconds’ exercise, three times per day. It works by training and strengthening the muscles, and by stimulating the brain to regenerate the pathways that control them. IQoro helps people with problems in swallowing, with hiatus hernia, facial paralysis, speech, snoring or sleep apnoea problems, and more.
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Medicon Village AB, the limited company that runs the science park, is owned by Mats Paulsson Foundation for Research, Innovation and Societal Development. The terms of the foundation stipulate that any surplus must be re-invested in research and innovation. In addition to the foundation’s board and the board of Medicon Village, there is a management group and another 20 people who look after our members and the daily running of The Village. They also look after external affairs and any contact with the outside world.
NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.
Novandi Chemistry offers a comprehensive carbon-14, tritium and stable isotope labeling service and acts as a hub for regulatory and non-regulatory studies with radiolabeled compounds and drug candidates. The company offers customers a long-term responsibility for radioactive labeled substances through storage and continuous quality control. Thus, the company can guarantee high quality compounds and simplify the logistics of studies with radiolabeled compounds.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organisations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets.
Rekryteringsspecialisten Life Science is a recruitment company specializing in Life Science, with clients throughout the Nordic countries. Commitment and focus define our quest to find the most suitable candidates for any position, with regard to competence and personality. We manage the entire process for both client and candidate.
We develop instruments, software and methods for the analysis of molecular interactions. Our instrument family LigandTracer is dedicated to cell-based real-time interaction analysis. The TraceDrawer evaluation software turns data evaluation efficient, both for LigandTracer and for several other instrument platforms on OEM basis. We also help companies and universities improving assays and methods as part of our consultancy program.
SINTEF is the largest independent research organisation in Scandinavia. We create value and innovation through knowledge generation and development of technological solutions that are brought into practical use. SINTEF is a broadly based, multidisciplinary research institute with international top-level expertise in technology, medicine and the social sciences. We conduct contract R&D as partner for the private and public sectors, and we are among the four largest contract research institutions in Europe.
SwedenBIO helps innovative companies succeed! SwedenBIO improves the business climate for our 200 member companies and the life science industry. In addition to advocacy and promotion of industry interests, through our member services we enable professional development and knowledge and experience exchange. We also run the EU Support Office, which helps companies obtain funding. And we've been successfully doing this for 10 years.
In 2012 a team of engineers, researchers, medical doctors, business strategists and IT-professionals in Sweden and Tanzania (the co-founders of The Maombi Foundation and DD Innovation) came together to create a solution that addresses problems using affordable and accessible mobile technology.
WntResearch utvecklar en ny typ av cancerläkemedel baserat på banbrytande forskning som visar att det kroppsegna proteinet Wnt-5a spelar en viktig roll för tumörcellernas förmåga att förflytta och sprida sig i kroppen. De allra flesta som avlider i cancer gör det till följd av tumörspridning (metastasering) och behovet av en specifik behandling för att motverka detta är därför mycket stort.